Sevigny Jeffrey
Insider CIK 1778483 · ABOS Director · PRVL Chief Medical Officer · RAPP Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2021-06-30 | 2021-07-02 | 34,000 | — | $0 | 34,000 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 89,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 122,439 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 400,342 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | A Award deriv | 2020-02-19 | 2020-03-11 | 89,000 | — | $0 | 89,000 | SEC↗ |